Medication info
Recapine Tablets (Lercanidipine Hydrochloride)

Recapine Tablets (Lercanidipine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Lercanidipine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
HURON Pharmaceuticals Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200502588 · Notified 2005.01.13 · Insurance code 670600540

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become apparent. For patients whose blood pressure is not controlled with this medicine, combination therapy with a beta blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; doses above this range do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment : Particular caution is required during initiation in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen is consistent in these patients, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
HURON Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medication is used in the treatment of essential hypertension classified as mild to moderate.

How to take

Adult dose

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become apparent. For patients whose blood pressure is not controlled with this medicine, combination therapy with a beta blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; doses above this range do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment : Particular caution is required during initiation in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen is consistent in these patients, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Precautions

This medication should not be administered to specific patients. For instance, it must not be taken by women who are pregnant or breastfeeding, those allergic to this drug or similar components, patients with severe heart disease, severe liver or kidney dysfunction, or children under 18 years. Furthermore, patients with arrhythmias or heart issues, mild to moderate liver or kidney impairment, those with a history of angina, individuals who consume alcohol frequently, and the elderly should use this medication with caution. While taking this medication, side effects such as facial flushing, swelling of the hands and feet, rapid heart rate, headache, dizziness, dyspepsia, nausea, and liver function abnormalities may occur. Particularly, liver function tests should be performed regularly, and if abnormalities are present, discontinuation of the medication is necessary. Abrupt cessation of this medication may worsen symptoms, so dosages should be gradually reduced according to the physician's instructions. Additionally, dizziness or drowsiness may occur, requiring caution when driving or operating machinery. This drug is metabolized in the liver, and its effectiveness may change when taken with certain drugs; therefore, consultation with a doctor or pharmacist is required, and grapefruit juice or alcohol should be avoided. It is safest for women who are pregnant or potentially pregnant, as well as those who are breastfeeding, to avoid this medication. The safety and efficacy of this medication have not been established in children and adolescents, so it should not be used in this population. While special caution is required for the elderly, dosage adjustments may not be necessary. In cases of overdose, severe hypotension or cardiac problems may arise, necessitating immediate medical attention, and this drug may not be removed by dialysis. Finally, this drug should be kept out of the reach of children, and it is important not to transfer it to another container in order to maintain product quality.

Side effects

flushing, peripheral edema, palpitations, tachycardia, hypotension, chest pain, angina, headache, dizziness, asthenia, fatigue, drowsiness, neurosis, dyspepsia, nausea, vomiting, abdominal pain, diarrhea, increased serum hepatic aminotransferase levels, polyuria, nocturia, gingival hyperplasia, rash, myalgia, body tremor, insomnia, dry mouth, hand paresthesia, cough, abdominal bloating, erectile dysfunction, arrhythmia, cold sweat, skin tingling, premature contractions, tongue rigidity, increased ventricular premature beats, dyspnea, gastrointestinal disorder

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Products that are for oral use should be stored at room temperature, specifically between 1 to 30 degrees Celsius. Export products are recommended to be stored at temperatures below 25 degrees Celsius. By storing it this way, the effectiveness and safety of the medication can be maintained.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.